Xtant Medical Holdings, Inc. financial data

Symbol
XTNT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
664 Cruiser Lane, Belgrade, MT
State of incorporation
DE
Fiscal year end
December 31
Former names
Bacterin International Holdings, Inc. (to 8/3/2015), K KITZ INC (to 5/21/2010)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 260 % -7.21%
Quick Ratio 148 % +23.1%
Debt-to-equity 88.3 % +0.96%
Return On Equity -6.71 % +75.2%
Return On Assets -3.56 % +75.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 130M shares +1.1%
Common Stock, Shares, Outstanding 130M shares +19.7%
Entity Public Float 25.8M USD +269%
Weighted Average Number of Shares Outstanding, Basic 130M shares +19.6%
Weighted Average Number of Shares Outstanding, Diluted 130M shares +19.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 111M USD +63.4%
Research and Development Expense 2.15M USD +163%
Selling and Marketing Expense 48.3M USD +76.1%
General and Administrative Expense 31.5M USD +79.7%
Operating Income (Loss) -13.6M USD -106%
Nonoperating Income (Expense) 8.66M USD -11.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.95M USD +43.5%
Income Tax Expense (Benefit) -1.62M USD -2844%
Net Income (Loss) Attributable to Parent -3.33M USD +62.3%
Earnings Per Share, Basic -0.01 USD/shares +87.5%
Earnings Per Share, Diluted -0.01 USD/shares +87.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.38M USD +30%
Accounts Receivable, after Allowance for Credit Loss, Current 21.2M USD +54.2%
Inventory, Net 40.5M USD +98.9%
Assets, Current 69M USD +74.3%
Property, Plant and Equipment, Net 8.84M USD +28.5%
Operating Lease, Right-of-Use Asset 1.12M USD -3.29%
Intangible Assets, Net (Excluding Goodwill) 9.22M USD -15.6%
Goodwill 7.3M USD +12.1%
Other Assets, Noncurrent 130K USD -29%
Assets 95.6M USD +46.6%
Accounts Payable, Current 6.88M USD +54.7%
Accrued Liabilities, Current 8.68M USD +38.7%
Liabilities, Current 28.3M USD +66.6%
Deferred Income Tax Liabilities, Net 21K USD
Operating Lease, Liability, Noncurrent 376K USD -47.8%
Other Liabilities, Noncurrent 34K USD
Liabilities 50.6M USD +47.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -175K USD
Retained Earnings (Accumulated Deficit) -251M USD -1.34%
Stockholders' Equity Attributable to Parent 45M USD +45.4%
Liabilities and Equity 95.6M USD +46.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.76M USD -156%
Net Cash Provided by (Used in) Financing Activities 5.18M USD +13.4%
Net Cash Provided by (Used in) Investing Activities -674K USD +96.1%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 130M shares +19.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.3M USD +91.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.48M USD +23.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 740K USD +45.4%
Deferred Tax Assets, Valuation Allowance 25.8M USD +24%
Deferred Tax Assets, Gross 26.6M USD +24.9%
Operating Lease, Liability 1.59M USD +11.1%
Depreciation 2.2M USD +69.2%
Payments to Acquire Property, Plant, and Equipment 773K USD +69.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.51M USD -78.2%
Lessee, Operating Lease, Liability, to be Paid 1.72M USD +9.85%
Property, Plant and Equipment, Gross 29.4M USD +15.8%
Operating Lease, Liability, Current 794K USD +62.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 680K USD +21.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 918K USD +71.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 128K USD -3.76%
Lessee, Operating Lease, Liability, to be Paid, Year Three 119K USD -74.7%
Deferred Tax Assets, Operating Loss Carryforwards 18.6M USD +35.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 296M USD +6.29%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 500K USD 0%
Depreciation, Depletion and Amortization 1.01M USD +113%
Interest Expense 3.2M USD +67.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%